Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL)

CUSIP: 76029N106

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
+852,634
Put/Call ratio
151%
SEC-reported price per share
$23.22
Number of holders
139
Value change
+$26,630,495
Number of buys
65
Open additional details 1 more signal available
Number of sells
76
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
84,030,529

Security key

76029N106

Report period

Q2 2023

Institutions

139

Top holders

10

Ownership snapshot

Top reported holders of REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Omega Fund IV, L.P.
Disclosed value leader
Omega Fund IV, L.P.
Comparable rows
0/15
Latest evidence
31 Mar 2023
3/4/5 13F Highest disclosed value: $103,049,420 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Omega Fund IV, L.P. has the largest disclosed position value at $103.05M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Omega Fund IV, L.P.'s linked filing trail.
Disclosed position value Top 5
Omega Fund IV, L.P. $103.05M
PRICE T ROWE ASSOCIATES INC /MD/ $97.05M
BAKER BROS. ADVISORS LP $80.85M
Redmile Group, LLC $67.32M
BlackRock Finance, Inc. $63.97M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Omega Fund IV, L.P.
3/4/5
10%+ Owner
—
mixed-class rows
$103,049,420
9,453,260 shares
mixed-class rows
— 14 Mar 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$97,054,000
5,495,616 shares
— 31 Mar 2023
BAKER BROS. ADVISORS LP
13F
Company
13F
—
denominator unverified
$80,852,425
4,578,280 shares
— 31 Mar 2023
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$67,319,708
3,811,988 shares
— 31 Mar 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$63,966,358
3,622,104 shares
— 31 Mar 2023
Omega Fund Management, LLC
13F
Company
13F
—
denominator unverified
$53,866,302
3,050,187 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
139
Shares
54,593,396
Rows available
139
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
138
Q2 2023 holders
139
Holder diff
1
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .